Trial Profile
Effect of Idelalisib on QTc interval in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Idelalisib (Primary)
- Indications Allergic rhinitis; Chronic lymphocytic leukaemia; Follicular lymphoma; Hodgkin's disease; Mantle-cell lymphoma; Myelofibrosis; Non-Hodgkin's lymphoma; Pancreatic cancer; Solid tumours; Waldenstrom's macroglobulinaemia
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 28 Dec 2015 Results published in Blood journal.
- 28 Dec 2015 New trial record